1-(2-Diphenylmethoxyethyl)-4-(3-phenylpropyl)piperazinedihydrochloride
1-(2-Diphenylmethoxyethyl)-4-(3-phenylpropyl)piperazinedihydrochloride Basic information
- Product Name:
- 1-(2-Diphenylmethoxyethyl)-4-(3-phenylpropyl)piperazinedihydrochloride
- Synonyms:
-
- 1-(2-benzhydryloxyethyl)-4-(3-phenylpropyl)piperazine
- GBR 12935
- 1-[2-(Diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine
- 1-Hydrocinnamyl-4-[2-(diphenylmethoxy)ethyl]piperazine
- Piperazine, 1-(2-(diphenylmethoxy)ethyl)-4-(3-phenylpropyl)-
- N-[3-tert-Butyl-1-(4-Methylphenyl)-1H-pyrazol-5-yl]-N-[4-[2-(4-Morpholinyl)ethoxy]naphthalen-1-yl]urea
- GBR-12935, 1-(2 -(diphenylMethoxy) ethyl) -4-(3-phenylpropyl) piperazine
- 1-(2-(Benzhydryloxy)ethyl)-4-(3-phenylpropyl)piperazine Maleate
- CAS:
- 76778-22-8
- MF:
- C28H34N2O
- MW:
- 414.58
- Product Categories:
-
- Dopamine receptor
- Mol File:
- 76778-22-8.mol
1-(2-Diphenylmethoxyethyl)-4-(3-phenylpropyl)piperazinedihydrochloride Chemical Properties
- Boiling point:
- 540.6±50.0 °C(Predicted)
- Density
- 1.067±0.06 g/cm3(Predicted)
- storage temp.
- Desiccate at -20°C
- solubility
- Soluble in DMSO
- form
- Powder
- pka
- 7.55±0.10(Predicted)
1-(2-Diphenylmethoxyethyl)-4-(3-phenylpropyl)piperazinedihydrochloride Usage And Synthesis
Uses
GBR 12935 is a potent, and selective dopamine reuptake inhibitor, with the binding constant (Kd) of 1.08 nM in COS-7 cells. GBR 12935 stimulates the locomotion activity in different mice strains but fails to induce stereotypy. Thus, GBR 12935 also prevents the d-Fenfluramine-induced head-twitch response in mice[1][2][3][4].
Definition
ChEBI: An N-alkylpiperazine that consists of piperazine bearing 2-(benzhydryloxy)ethyl and 3-phenylpropyl groups at positions 1 and 4 respectively. Potent and selective inhibitor of dopamine uptake (KD = 5.5 nM in rat stria al membranes).
Biological Activity
Potent and selective inhibitor of dopamine uptake (K D = 5.5 nM in rat striatal membranes).
in vivo
GBR 12935 (1-32 mg/kg; repeat injection; 7 d) elevates locomotion activity to a greater extent in C57BL/6J mice than DBA/2J mice, and (10 mg/kg; injection; 7 d) results few mice sensitized to cocaine-induced stereotypy with repeated injections[3].
| Animal Model: | Adult male DBA/2J and C57BL/6J mice (22-30 g)[3] |
| Dosage: | 1.0, 3.2, 10, 32 mg/kg |
| Administration: | Repeat injection; for 7 days |
| Result: | Elevated locomotion activity to a greater extent in C57BL/6J mice than DBA/2J mice. No stereotypy was induced by an eighth day challenge of 10 mg/kg GBR 12935 in mice pretreated with seven dally injections of either 32 mg/kg cocaine or saline. |
References
[1] Hiroi T, et al. Specific binding of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl propyl) piperazine (GBR-12935), an inhibitor of the dopamine transporter, to human CYP2D6. Biochem Pharmacol. 1997 Jun 15;53(12):1937-9. DOI:10.1016/s0006-2952(97)00172-x
[2] Rahman S, et al. Negative interaction of dopamine D2 receptor antagonists and GBR 12909 and GBR 12935 dopamine uptake inhibitors in the nucleus accumbens. Eur J Pharmacol. 2001 Feb 23;414(1):37-44. DOI:10.1016/s0014-2999(01)00785-3
[3] Tolliver BK, et al. Comparison of cocaine and GBR 12935: effects on locomotor activity and stereotypy in two inbred mouse strains. Pharmacol Biochem Behav. 1994 Jul;48(3):733-9. DOI:10.1016/0091-3057(94)90340-9
[4] Darmani NA. Cocaine and selective monoamine uptake blockers (sertraline, nisoxetine, and GBR 12935) prevent the d-fenfluramine-induced head-twitch response in mice. Pharmacol Biochem Behav. 1998 May;60(1):83-90. DOI:10.1016/s0091-3057(97)00548-0
1-(2-Diphenylmethoxyethyl)-4-(3-phenylpropyl)piperazinedihydrochlorideSupplier
- Tel
- sales@boylechem.com
- Tel
- 821-50328103-801 18930552037
- 3bsc@sina.com
- Tel
- +86 (25) 5860-8846
- kt_chem@126.com
- Tel
- 86-21-37788339
- Tel
- 021-60345187 13671753212
- lzz841106@aliyun.com